International Journal of Nanomedicine,
Год журнала:
2024,
Номер
Volume 19, С. 11445 - 11462
Опубликована: Ноя. 1, 2024
The
poor
delivery
and
limited
penetration
of
nanoparticles
into
breast
cancer
tumors
remain
essential
challenges
for
effective
anticancer
therapy.
This
study
aimed
to
design
a
promising
nanoplatform
with
efficient
tumor
targeting
capability
International Journal of Nanomedicine,
Год журнала:
2025,
Номер
Volume 20, С. 1367 - 1382
Опубликована: Фев. 1, 2025
Abstract:
Breast
cancer
remains
a
significant
therapeutic
challenge,
with
the
immune
microenvironment
playing
crucial
role
in
its
progression
and
treatment
response.
This
review
investigates
potential
of
nanoparticles
to
modulate
breast
therapy.
Initially,
we
discuss
composition
influence
on
cancer,
followed
by
current
strategies
targeting
these
components.
We
then
provide
for
cells
such
as
macrophages,
dendritic
cells,
T-cells.
The
enhancing
checkpoint
blockade
(ICB)
their
application
vaccines
is
also
examined.
Additionally,
explore
synergistic
effects
combining
conventional
therapies.
addresses
challenges
clinical
translation,
focusing
safety,
biocompatibility,
toxicity.
Finally,
outline
future
research
directions
advancements
nanoparticle-based
immunotherapy,
emphasizing
transformative
impact
treatment.
Keywords:
nanoparticle,
ACS Applied Materials & Interfaces,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 13, 2025
Single-atom
nanozymes
are
highly
effective
in
the
preparation
of
tumor
vaccines
(TV)
due
to
their
superior
peroxidase
(POD)
activity
and
excellent
biocompatibility.
However,
immunosuppressive
environment
within
tumors
can
diminish
efficacy
these
vaccines.
Cold
exposure
(CE)
therapy,
a
noninvasive
straightforward
antitumor
method,
not
only
suppresses
metabolism
but
also
ameliorates
milieu.
In
this
study,
we
developed
personalized
TV
using
copper
single-atom
nanozyme
(Cu
SAZ)
enhanced
long-term
by
introducing
CE.
We
initially
synthesized
Cu
SAZ
via
high-temperature
carbonization,
which
demonstrated
robust
POD
photothermal
characteristics.
Upon
808
nm
laser
irradiation,
generated
reactive
oxygen
species
(ROS)
heat,
inducing
immunogenic
cell
death
4T1
breast
cancer
cells
or
CT26
colon
facilitating
production.
our
vivo
prevention
treatment
model,
noted
that
CE
significantly
boosted
TV.
The
primary
mechanism
involves
CE's
ability
lower
ratio
myeloid-derived
suppressor
(MDSCs),
decrease
glucose
cells,
increase
proportions
CD8+
T
memory
cells.
Collectively,
findings
offer
promising
avenues
for
designing
innovative
systems.
Journal of Nanobiotechnology,
Год журнала:
2025,
Номер
23(1)
Опубликована: Март 7, 2025
Limited
treatment
response
and
inadequate
monitoring
methods
stand
firmly
before
successful
immunotherapy.
Recruiting
activating
immune
cells
in
the
hypoxic
tumor
microenvironment
is
key
to
reversing
suppression
improving
immunotherapy
efficacy.
In
this
study,
biomimetic
oxygen-delivering
nanoparticles
(CmPF)
are
engineered
for
homologous
targeting
hypoxia
alleviation
within
environment.
CmPF
targets
delivers
oxygen
reduce
hypoxia,
thereby
promoting
cell
activity
at
site.
addition,
granzyme
B-targeted
positron
emission
tomography
(PET)
imaging
employed
monitor
changes
efficacy
vivo.
The
combination
of
with
carboplatin
PD-1
inhibitors
significantly
suppresses
growth
by
2.4-fold,
exhibiting
potential
enhance
Immunohistochemistry
further
confirms
increased
expression
markers,
highlighting
reprogramming
microenvironment.
This
study
demonstrates
that
enhances
introduces
a
non-invasive
PET
method
dynamic,
real-time
assessment
therapeutic
response.
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 5, 2025
Near-infrared
(NIR)
activated
photosensitizers
based
on
heavy-atom-free
have
great
advantages
in
photoimmunotherapy,
yet
the
tumor
microenvironment
often
restricts
their
efficacy.
To
address
this,
a
NIR-activated
photosensitizer
(named
Cy-BF)
is
developed.
Cy-BF
then
encapsulated
with
phospholipids
and
platelet
exosome
vesicles
to
create
exosomes
biomimetic
loaded
hybrid
liposomes
CHL)
Characterized
by
high
phototoxicity,
low
dark
toxicity,
enhanced
targeting,
CHL
demonstrates
aggregation-induced
broadening
of
absorption
spectra
NIR
(760
nm
laser)
activates
photothermal
therapy
type
I
photodynamic
therapy.
The
CHL-mediated
phototherapy
induces
mitochondrial
damage
immunogenic
cell
death
cells,
decreases
lactate
production,
alters
reducing
regulatory
T
cells
increasing
CD8+
cells.
mitigate
inhibition
excess
lactate,
combination
introduced
using
lithium
carbonate,
which
repurposes
as
an
energy
source
for
thereby
enhancing
effectiveness
photoimmunotherapy.
This
approach
represents
novel
strategy
reversing
metabolism
both
paving
way
future
clinical
applications
Journal of Nanobiotechnology,
Год журнала:
2025,
Номер
23(1)
Опубликована: Март 19, 2025
Inducing
ferroptotic
cell
death
has
been
recognized
as
a
promising
approach
in
cancer
therapy.
However,
ferroptosis
can
provoke
tumor
infiltration
by
myeloid-derived
suppressor
cells
(MDSCs)
through
HMGB1
secretion,
causing
suppressive
immune
response.
On
the
other
hand,
also
occurs
due
to
its
non-selective
properties,
which
compromise
anti-tumor
immunity.
To
address
these
challenges,
two-pronged
is
proposed,
encompassing
selectively
triggered
and
blockade,
aimed
at
eliciting
systemic
immunity
alleviating
immunosuppression.
Herein,
GSH-specific
driven
nanoplatform
composed
of
uniform
FeOOH
nanospindles
coated
with
tetrasulfide
bond-bridged
mesoporous
organosilica
(DMOS)
shell,
loaded
inhibitor,
glycyrrhizic
acid
(GA).
This
endowed
high
glutathione
(GSH)
depletion
efficiency
exhibits
highly
efficient
Fe2+
ROS
generation
capacity,
promotes
accumulation
LPO
subsequently
induces
ferroptosis.
Concurrently,
inhibition
release
counteracts
immunosuppressive
effects
within
microenvironment.
innovative
effectively
suppresses
growth
4T1
tumors
notably
enhancing
therapeutic
outcomes
checkpoint
blockade
across
experimental
data.
The
collective
findings
indicate
potential
reliable
strategy
for
boosting
ferroptosis-mediated
favorable
safety
profiles.
Journal of Nanobiotechnology,
Год журнала:
2025,
Номер
23(1)
Опубликована: Апрель 4, 2025
Nanocatalysis
coupled
with
photothermal
therapy
is
a
potent
anti-cancer
approach,
yet
its
clinical
utility
limited
by
low
concentration
of
tumor
substrate,
redox
interference,
and
risks
overheating
normal
tissues.
Herein,
we
propose
an
innovative
closed-loop
nanozyme
approach
that
leverages
the
synergistic
effects
catalytic
mild
(mPTT)
to
address
aforementioned
challenges.
The
strategy
features
folic
acid-functionalized
iron
single-atom
catalyst
(FeNC-FA),
designed
exhibit
exceptional
multienzymatic
capabilities
optimal
response.
In
system,
engineered
FeNC-FA
capable
inducing
reactive
oxygen
species
(ROS)
storm
depleting
glutathione
(GSH)
in
specific
microenvironment
(TME)
initiate
ferroptosis.
Concurrently,
accumulation
ROS
effectively
cleaves
heat
shock
proteins
(HSPs),
thereby
enhancing
mPTT.
An
intriguing
aspect
increased
temperature
within
TME
further
facilitates
conversion
H2O2
O2,
alleviating
hypoxia
providing
positive
feedback
circuit
boost
therapy.
Additionally,
advanced
photoacoustic
(PA)
imaging
allow
for
self-monitoring
their
at
sites,
guiding
mPTT
process.
Taken
together,
it
provides
PA
image-guided,
mutually
reinforced
both
vitro
vivo.
This
targeted
holds
great
promise
personalized
medicine
applications.
Journal of Nanobiotechnology,
Год журнала:
2025,
Номер
23(1)
Опубликована: Апрель 7, 2025
Abstract
Breast
cancer
is
the
most
commonly
diagnosed
worldwide.
Despite
advancements
in
therapeutic
modalities,
its
prognosis
remains
poor
owing
to
complex
clinical,
pathological,
and
molecular
characteristics.
Sonodynamic
therapy
(SDT)
a
promising
approach
for
tumor
elimination,
using
sonosensitizers
that
preferentially
accumulate
tissues
are
activated
by
low-intensity
ultrasound
produce
reactive
oxygen
species.
However,
clinical
translation
of
SDT
faces
challenges,
including
limited
efficiency
resistance
posed
microenvironment.
The
emergence
nanomedicine
offers
innovative
strategies
address
these
obstacles.
This
review
discusses
enhancing
efficacy
sonosensitizers,
rational
structural
modifications,
improved
tumor-targeted
enrichment,
microenvironment
remodeling,
imaging-guided
therapy.
Additionally,
SDT-based
multimodal
therapies,
such
as
sono-chemotherapy,
sono-immunotherapy,
sono-photodynamic
therapy,
their
potential
applications
breast
treatment
summarized.
underlying
mechanisms
briefly
outlined.
Finally,
this
highlights
current
challenges
prospects
SDT,
providing
insights
into
future
may
improve
outcomes
cancer.
Graphical
abstract
International Journal of Nanomedicine,
Год журнала:
2024,
Номер
Volume 19, С. 11923 - 11940
Опубликована: Ноя. 1, 2024
Ferroptosis-driven
tumor
ablation
strategies
based
on
nanotechnology
could
be
achieved
by
elevating
intracellular
iron
levels
or
inhibiting
glutathione
peroxidase
4
(GPX4)
activity.
However,
the
antioxidative
defense
mechanisms
endow
cells
with
ferroptosis
resistance
capacity.
The
purpose
of
this
study
was
to
develop
a
synergistic
therapeutic
platform
enhance
efficacy
ferroptosis-based
therapy.
In
study,
multifunctional
nano-catalytic
(mFeB@PDA-FA)
chemodynamic
therapy
(CDT)
and
photothermal
(PTT)
developed
effectively
trigger
in
tumor.
our
work,
iron-based
mesoporous
Fe3O4
nanoparticles
(mFe3O4
NPs)
were
employed
for
encapsulation
L-buthionine
sulfoximine
(BSO),
followed
modification
folic
acid-functionalized
polydopamine
(PDA)
coating
periphery.
Then,
antitumor
effect
mFeB@PDA-FA
NPs
evaluated
using
Human
OS
(MNNG/HOS)
subcutaneous
xenograft
model
osteosarcoma.
mFe3O4
harboring
multivalent
elements
(Fe2+/3+)
catalyze
hydrogen
peroxide
(H2O2)
into
highly
cytotoxic
˙OH,
while
microenvironment
(TME)-responsive
released
BSO
molecules
inhibit
biosynthesis
GSH,
thus
achieving
deactivation
GPX4
enhancement
ferroptosis.
Moreover,
thanks
remarkable
conversion
performance
PDA
shell,
PTT
further
synergistically
enhanced
CDT
facilitated
Both
vivo
vitro
experiments
confirmed
that
achieve
excellent
inhibition
effects.
nanotherapeutic
disrupted
redox
homeostasis
boosting
through
combination
CDT,
GSH
elimination,
which
provided
new
perspective
treatment
sensitive
tumors.
Nanomaterials,
Год журнала:
2024,
Номер
14(22), С. 1781 - 1781
Опубликована: Ноя. 5, 2024
The
aim
of
the
study
is
to
formulate
an
injectable
nanocrystalline
suspension
(NS)
dutasteride
(DTS),
a
hydrophobic
5α-reductase
inhibitor
used
treat
benign
prostatic
hyperplasia
and
scalp
hair
loss,
for
parenteral
long-acting
delivery.
A
DTS-loaded
NS
(DTS-NS,
40
mg/mL
DTS)
was
prepared
using
lab-scale
bead-milling
technique.
optimized
DTS-NS
Tween
80
(0.5%